Journal
JOURNAL OF PERSONALIZED MEDICINE
Volume 8, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/jpm8030028
Keywords
pharmacometabolomics; metabolomics; pharmacogenomics; therapeutic drug monitoring; personalized medicine; mass spectrometry
Funding
- Program for Basic Research of State Academies of Sciences for 2013-2020
Ask authors/readers for more resources
The optimization of drug therapy according to the personal characteristics of patients is a perspective direction in modern medicine. One of the possible ways to achieve such personalization is through the application of omics technologies, including current, promising metabolomics methods. This review demonstrates that the analysis of pre-dose metabolite biofluid profiles allows clinicians to predict the effectiveness of a selected drug treatment for a given individual. In the review, it is also shown that the monitoring of post-dose metabolite profiles could allow clinicians to evaluate drug efficiency, the reaction of the host to the treatment, and the outcome of the therapy. A comparative description of pharmacotherapy personalization (pharmacogenomics, pharmacoproteomics, and therapeutic drug monitoring) and personalization based on the analysis of metabolite profiles for biofluids (pharmacometabolomics) is also provided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available